Jekeseni wa Brolucizumab-dbll

Zamkati

• Asanalandire jakisoni wa brolucizumab-dbll,
• Zotsatira zoyipa kuchokera ku jakisoni wa brolucizumab-dbll zitha kukhala zowopsa. Ngati mukukumana ndi zina mwazizindikirozi, pitani kuchipatala nthawi yomweyo kapena pitani kuchipatala:

Jekeseni wa Brolucizumab-dbll amagwiritsidwa ntchito pochiza kuchepa kwamankhwala okhudzana ndi zaka (AMD; matenda opitilira diso omwe amachititsa kuti asamaoneke kutsogolo ndipo zitha kupangitsa kuti zikhale zovuta kuwerenga, kuyendetsa, kapena kuchita zina tsiku lililonse) . Brolucizumab-dbll ali mgulu la mankhwala otchedwa vascular endothelial growth factor A (VEGF-A). Zimagwira ntchito poletsa kukula kwa chotengera chamagazi ndikutuluka m'maso komwe kumatha kuyambitsa kutaya kwamaso.

Brolucizumab-dbll imabwera ngati yankho (madzi) kuti alowe m'diso ndi dokotala. Nthawi zambiri amaperekedwa ku ofesi ya dokotala kamodzi masiku 25 mpaka 31 pamiyeso itatu yoyamba, kamodzi kamodzi pamasabata 8 mpaka 12.

Musanalandire jakisoni wa brolucizumab-dbll, dokotala wanu amayeretsa diso lanu kuti muteteze matenda ndikufewetsa diso lanu kuti muchepetse mavuto mukamayamwa. Mutha kukakamizidwa m'maso mwanu mukalandira mankhwala. Pambuyo pa jakisoni wanu, dokotala wanu ayenera kukuyang'anirani musanatuluke muofesi.

Brolucizumab-dbll imayang'anira AMD yonyowa, koma siyichiritsa. Dokotala wanu adzakuyang'anirani mosamala kuti muwone momwe brolucizumab-dbll imagwirira ntchito kwa inu. Lankhulani ndi dokotala wanu za kutalika kwa nthawi yomwe muyenera kupitiliza kulandira mankhwala ndi brolucizumab-dbll.

Funsani wamankhwala kapena dokotala wanu kuti mumupatseko zidziwitso za wopanga kwa wodwalayo.

Mankhwalawa amatha kupatsidwa ntchito zina; funsani dokotala wanu kapena wamankhwala kuti mudziwe zambiri.

Asanalandire jakisoni wa brolucizumab-dbll,

• uzani dokotala wanu komanso wamankhwala ngati muli ndi vuto la brolucizumab-dbll, mankhwala ena aliwonse, kapena zosakaniza zilizonse mu jakisoni wa brolucizumab-dbll. Funsani wamankhwala wanu kuti awonetse mndandanda wazosakaniza.
• auzeni adotolo komanso asayansi yanu mankhwala ena omwe mungalandire kapena omwe simukulembera, mavitamini, zowonjezera zakudya, komanso mankhwala azitsamba omwe mukumwa kapena omwe mukufuna kumwa.
• uzani dokotala wanu ngati muli ndi matenda m'diso kapena mozungulira. Dokotala wanu angakuuzeni kuti simuyenera kulandira jakisoni wa brolucizumab-dbll.
• Uzani dokotala wanu ngati mukudwala.
• Uzani dokotala wanu ngati muli ndi pakati kapena mukufuna kukhala ndi pakati. Simuyenera kutenga pakati mukamalandira chithandizo cha jakisoni wa brolucizumab-dbll komanso kwa mwezi umodzi mutapatsidwa mankhwala omaliza. Mukakhala ndi pakati mukalandira jakisoni wa brolucizumab-dbll, itanani dokotala wanu.
• uzani dokotala wanu ngati mukuyamwitsa. Musamayamwitse pamene mukulandira jakisoni wa brolucizumab-dbll komanso kwa mwezi umodzi mutapatsidwa mankhwala omaliza.
• muyenera kudziwa kuti jakisoni wa brolucizumab-dbll angayambitse mavuto m'maso mutangolandira jakisoni. Osayendetsa galimoto kapena kugwiritsa ntchito makina mpaka masomphenya anu abwerera mwakale.

Pokhapokha dokotala atakuwuzani zina, pitirizani kudya zomwe mumadya.

Ngati mwaphonya nthawi kuti mulandire jakisoni wa brolucizumab-dbll, itanani dokotala wanu posachedwa.

Zotsatira zoyipa kuchokera ku jakisoni wa brolucizumab-dbll zitha kukhala zowopsa. Ngati mukukumana ndi zina mwazizindikirozi, pitani kuchipatala nthawi yomweyo kapena pitani kuchipatala:

• kupweteka kwa diso, kufiira, kapena kuzindikira kuwala
• kusintha kwa masomphenya
• powona '' zoyandama '' kapena timadontho tating'ono
• kutuluka magazi mkati kapena mozungulira diso
• kutupa kwa diso kapena chikope
• zidzolo, ming'oma, kuyabwa, kapena kufiira

Brolucizumab-dbll ingayambitse zovuta zina. Itanani dokotala wanu ngati muli ndi zovuta zina mukalandira mankhwalawa.

Mukakumana ndi zovuta zina, inu kapena adokotala mutha kutumiza lipoti ku pulogalamu ya Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting pa intaneti (http://www.fda.gov/Safety/MedWatch) kapena pafoni ( 1-800-332-1088).

Sungani maimidwe onse ndi dokotala wanu.

Funsani wamankhwala wanu mafunso aliwonse omwe mungakhale nawo pa jakisoni wa brolucizumab-dbll.

Ndikofunika kuti musunge mndandanda wamankhwala onse omwe mumalandira komanso osalembetsa (owerengera) omwe mukumwa, komanso zinthu zilizonse monga mavitamini, michere, kapena zakudya zina. Muyenera kubwera nawo pamndandandawu nthawi iliyonse mukapita kukaonana ndi dokotala kapena ngati mwalandiridwa kuchipatala. Ndikofunikanso kuthana nanu pakagwa mwadzidzidzi.

• Beovu^®